Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Buy Rating for Controladora Vuela with Revised Price Target

Elaine Mendonca by Elaine Mendonca
January 27, 2024
in Breaking News
0
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

On January 27, 2024, Bruno Amorim, an analyst from Goldman Sachs, expressed his positive stance on Controladora Vuela (NYSE:VLRS) by maintaining a Buy rating. However, he revised the price target for the stock from $12.4 to $11.1. Amorim’s decision to adjust the price target is based on his evaluation of the company’s future performance in the stock market. Investors should take this updated price target into account when making their investment decisions.

VLRS Stock: Decline in Price Momentum, but Potential Positive Developments in After-Hours Trading

On January 27, 2024, VLRS stock experienced a decline in its price momentum, as it was trading near the bottom of its 52-week range and below its 200-day simple moving average. The price of VLRS shares decreased by $0.12 since the market last closed, representing a drop of 1.47%. However, there was a slight improvement in the stock’s performance during after-hours trading, as it rose by $0.16. After-hours trading can be volatile and may not always reflect the true market sentiment. Overall, VLRS stock had a relatively weak performance on January 27, 2024, but the slight increase in after-hours trading suggests that there may have been some positive developments surrounding VLRS that could potentially impact its future performance.

VLRS Stock Performance: Mixed Results as Total Revenue Rises, Net Income and EPS Decline

VLRS stock performances on January 27, 2024, showed mixed results as the company’s total revenue increased while net income and earnings per share (EPS) decreased. Starting with the total revenue, VLRS reported a total revenue of $2.85 billion in the past year, representing a 28.1% increase compared to the previous year. Additionally, the company’s total revenue increased by 9.06% since the last quarter, reaching $852.83 million. However, the net income for VLRS tells a different story. The company reported a net income of -$80.22 million in the past year, indicating a decrease of 176.76% compared to the previous year. Furthermore, the net income decreased by a significant 753.7% since the last quarter, reaching -$39.22 million. The earnings per share (EPS) for VLRS also experienced a decline. Over the past year, the company reported an EPS of -$0.69, reflecting a decrease of 177.49% compared to the previous year. Similarly, the EPS decreased by 750.38% since the last quarter, reaching -$0.34. Overall, VLRS stock performances on January 27, 2024, showed a mixed picture. Investors should closely monitor VLRS’s financial performance in the coming quarters to assess whether the company can address its profitability challenges and improve its earnings.

Tags: VLRS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Chart up

Goldman Sachs Analyst Expresses Optimism for United Rentals

KEYTRUDA Shows Promising Results as Adjuvant Therapy in Urothelial Carcinoma

MMM stock news

Citigroup Analyst Maintains Neutral Rating on Tesla with Reduced Price Target

Recommended

CRWD stock news

Tower Research Capital LLC TRC Demonstrates Unwavering Confidence in CrowdStrike Holdings as Cybersecurity Leader

2 years ago
Efficiently Reporting an Absence on WalmartOne: A Step-by-Step Guide for Employees

Beacon Announces Interim Chief Financial Officer

2 years ago

Alaska Airlines Boeing 737 Investigation Missing Bolts and Safety Measures

2 years ago

Impressive Financial Performance for Kiniksa Pharmaceuticals

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Trending

Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

by Rodolfo Hanigan
February 7, 2026
0

Universal Insurance Holdings has reaffirmed its commitment to shareholder returns, declaring its regular quarterly dividend despite a...

Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com